Key findings
Library coverage
PepFlow publishes 65 unique peptide profiles across 19 primary classes.
Strong evidence label
In PepFlow’s public peptide library, 11 of 65 (17%) profiles carry its Strong editorial evidence label.
Limited or Insufficient evidence labels
In PepFlow’s public peptide library, 23 of 65 (35%) profiles carry its Limited or Insufficient editorial evidence label.
Peptide guide coverage
In PepFlow’s public peptide library, 65 of 65 (100%) profiles have a published dosage guide.
Peptide and stack guides
PepFlow’s 73 published dosage guides include 65 peptide guides and 8 stack guides. Stack guides account for 8 of 73 (11%) guides in the directory.
Profiles by primary class
| Primary class | Profiles | Share of profiles |
|---|---|---|
| GH/IGF axis peptide | 12 | 18% |
| Neuroactive peptide | 8 | 12% |
| Redox/NAD metabolism compound | 5 | 8% |
| Tissue-specific peptide bioregulator | 5 | 8% |
| Endocrine/reproductive hormone | 4 | 6% |
| Incretin/amylin analog | 4 | 6% |
| Matrikine/copper tripeptide | 4 | 6% |
| Melanocortin pathway peptide | 4 | 6% |
| Endogenous fragment peptide | 3 | 5% |
| Immune signaling peptide | 3 | 5% |
| Mitochondrial peptide | 3 | 5% |
| Bioregulator peptide | 2 | 3% |
| Tissue-derived peptide complex | 2 | 3% |
| Activin-binding glycoprotein | 1 | 2% |
| Cell-penetrating peptide | 1 | 2% |
| Growth hormone fragment | 1 | 2% |
| Thymic hormone | 1 | 2% |
| Thymic peptide and actin-binding protein | 1 | 2% |
| Thymus-derived peptide extract | 1 | 2% |
Profiles by evidence label
| Evidence label | Profiles | Share of profiles |
|---|---|---|
| Strong | 11 | 17% |
| Moderate | 10 | 15% |
| Emerging | 7 | 11% |
| Preliminary | 14 | 22% |
| Limited | 16 | 25% |
| Insufficient | 7 | 11% |
Dosage guide coverage
| Entry type | Public profiles | Published guides | Share with a guide |
|---|---|---|---|
| Peptide profiles | 65 | 65 | 100% |
| Stack profiles | 8 | 8 | — |
Methodology
- Count distinct public catalog slugs by entry type. Use one primary class and one editorial evidence label per peptide profile, and match guide coverage against the website publication list. Aliases do not add rows. Draft guides, non-stack taxonomy pages, and app translations are excluded.
- The catalog fields are maintained by PepFlow’s editorial team. Evidence labels summarize PepFlow’s review of the relevant claims. Guide coverage measures publication, and a published guide does not establish a validated regimen.
- Percentages use the denominator shown for each finding or table. They are rounded to the nearest whole percent, so displayed shares can sum to more or less than 100%. A dash marks a denominator below 20.
- The figures regenerate with the website build from the current catalog and publication list. The source date comes from recorded catalog reviews and the guide publication list’s change date.
- Latest recorded peptide profile review was October 25, 2026. Latest recorded stack profile review was August 17, 2026.
Frequently asked questions
How many peptide profiles does PepFlow publish?
PepFlow publishes 65 unique peptide profiles across 19 primary classes.
How many PepFlow profiles carry the Strong evidence label?
In PepFlow’s public peptide library, 11 of 65 (17%) profiles carry its Strong editorial evidence label.
How many profiles carry Limited or Insufficient evidence labels?
In PepFlow’s public peptide library, 23 of 65 (35%) profiles carry its Limited or Insufficient editorial evidence label.
How many PepFlow peptide profiles have a published dosage guide?
In PepFlow’s public peptide library, 65 of 65 (100%) profiles have a published dosage guide.
How many peptide and stack dosage guides does PepFlow publish?
PepFlow’s 73 published dosage guides include 65 peptide guides and 8 stack guides. Stack guides account for 8 of 73 (11%) guides in the directory.
Suggested citation
PepFlow. PepFlow Library Statistics (2026) · 65 Profiles. Source data through October 2026. https://pepflow.app/research/peptide-library/